nimesulide has been researched along with Infarction, Middle Cerebral Artery in 2 studies
nimesulide: structure
nimesulide : An aromatic ether having phenyl and 2-methylsulfonamido-5-nitrophenyl as the two aryl groups.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
Excerpt | Relevance | Reference |
---|---|---|
" The purpose of this study was to evaluate the neuroprotective effects of the selective COX-2 inhibitor nimesulide on cerebral infarction and neurological deficits in a standardized model of transient focal cerebral ischemia in rats." | 3.72 | Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat. ( Candelario-Jalil, E; Fiebich, BL; García-Cabrera, M; González-Falcón, A; León, OS, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Candelario-Jalil, E | 2 |
González-Falcón, A | 2 |
García-Cabrera, M | 2 |
León, OS | 2 |
Fiebich, BL | 2 |
2 other studies available for nimesulide and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cerebral Infarction; Dinoprostone; Disease Models, | 2004 |
Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats.
Topics: Animals; Blood-Brain Barrier; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Leukocytes; Mal | 2007 |